Found 4 matching trials
Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
PHASE1This is a single-center study to investigate the effects of a topical cream...
Location
University of Miami Department of Dermatology
Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma
PHASE2The purpose of this study is to determine the safety and tolerability of ph...
Location
Multiple Locations
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma
PHASE1The purpose of this study is to determine the safety and tolerability of ph...
Location
Burke Pharmaceuticals
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
PHASE1The purpose of this study is to determine the safety and tolerability of ph...
Location
Burke Pharmaceuticals